Hep B sAg Antibody (S 38) is a mouse monoclonal IgG1 antibody that detects Hep B sAg of Hepatitis B by immunoprecipitation (IP), immunofluorescence (IF), and flow cytometry (FCM). Hep B sAg is a crucial protein antigen produced by the Hepatitis B virus, serving as one of the earliest markers of infection, often detectable in the bloodstream before clinical symptoms appear. Early detection enables timely diagnosis and management of Hepatitis B, which causes severe liver inflammation and increases risk of developing hepatocellular carcinoma. Active viral replication is indicated by Hep B sAg presence, making anti-Hep B sAg antibody (S 38) essential for monitoring disease progression and response to antiviral therapies. Understanding Hep B sAg dynamics during infection supports development of effective treatment strategies and public health interventions to control viral spread, which currently affects over 250 million people globally. Anti-Hep B sAg antibody (S 38) serves as a valuable tool for researchers and clinicians studying Hepatitis B infection and liver health implications.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Hep B sAg Antibody (S 38) References:
- Hepatitis B surface antigen-positive but DNA-negative patients. | Alter, MJ. 2001. Semin Dial. 14: 230-1. PMID: 11422934
- Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. | Iyer, S., et al. 2004. Vaccine. 22: 1475-9. PMID: 15063571
- Negative evaluation of a pathergy test in hepatitis B surface antigen carriers. | Engin, B. and Güner, OR. 2006. J Dermatol. 33: 547-9. PMID: 16923136
- Development of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen. | Tong, MJ., et al. 2009. Clin Gastroenterol Hepatol. 7: 889-93. PMID: 19394445
- Mutational analysis of hepatitis B surface antigen particle assembly and secretion. | Bruss, V. and Ganem, D. 1991. J Virol. 65: 3813-20. PMID: 2041095
- Artificial neural network accurately predicts hepatitis B surface antigen seroclearance. | Zheng, MH., et al. 2014. PLoS One. 9: e99422. PMID: 24914537
- Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation. | Moal, V., et al. 2015. J Clin Virol. 68: 32-6. PMID: 26071332
- A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha. | Cao, Z., et al. 2017. Hepatology. 66: 1058-1066. PMID: 28407271
- Hepatitis B surface antigen in human subretinal fluid. | Friberg, TR. and Williamson, D. 1983. Am J Ophthalmol. 95: 712-3. PMID: 6846465
- Removal of hepatitis B surface antigen from a contaminated applanation tonometer. | Moniz, E., et al. 1981. Am J Ophthalmol. 91: 522-5. PMID: 7223825